hy-50 (sodium hyaluronate sterile injection 17mg/ml)
dechra ltd - sodium hyaluronate - parenteral liquid/solution/suspension - sodium hyaluronate ungrouped active 17.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - inflammatory joint disease | non-infectious joint disease
hy-50 vet 17 mg/ml inj. sol. i.artic./i.v. pre-filled syr.
dechra regulatory b.v. - sodium hyaluronate 17 mg/ml - solution for injection - 17 mg/ml - sodium hyaluronate 17 mg/ml - hyaluronic acid - horse
hy-50 vet. 17 mg/ml solution for injection for horses
dechra regulatory b.v. - sodium hyaluronate - solution for injection - 17 milligram(s)/millilitre - hyaluronic acid
hy-50 vet. 17 mg/ml solution for injection for horses
dechra limited - hyaluronate sodium - solution for injection - 17 mg/ml - hyaluronic acid - equine - miscellaneous
enhance i.a./i.v. sodium hyaluronate injection for horses
vetoquinol australia pty ltd - sodium hyaluronate - parenteral liquid/solution/suspension - sodium hyaluronate ungrouped active 10.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - non-infectious acute synovitis
nexha- hyaluronate sodium injection, solution
bioniche animal health usa, inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - hyaluronate sodium 10 mg in 1 ml - nexhatm (hyaluronate sodium) injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. there are no known contraindications for the use of nexhatm (hyaluronate sodium) injectable solution in horses.
sodium hyaluronate
randlab australia pty ltd - sodium hyaluronate - unknown - sodium hyaluronate ungrouped active 0.0 - active constituent
sodium hyaluronate
dechra veterinary products (australia) pty. ltd. - sodium hyaluronate - unknown - sodium hyaluronate ungrouped active 0.0 - active constituent
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.